RESMED INC

RMD 10-K · FY 2025

RMD FY 2025 request

Playground key active
Request URL /api/financials?ticker=RMD&year=2025&quarter=4&full_year_mode=true
waiting 0 ms
Pick an endpoint and run the request.
curl

Income Statement

Income Statement
Metric FY 2025 FY 2024 YoY
Revenue 5,146,327 4,685,297 +9.8%
Show Product Lines breakouts
Residential Care Software 641,437 584,125 +9.8%
Sleep and Breathing Health 4,504,890 4,101,172 +9.8%
Show Business Segments breakouts
Residential Care Software 641,437 584,125 +9.8%
Sleep and Breathing Health 4,504,890 4,101,172 +9.8%
Sleep and Breathing Health · Combined Europe, Asia and other markets 1,507,376 1,378,616 +9.3%
Sleep and Breathing Health · Combined Europe, Asia and other markets 1,010,760 921,253 +9.7%
Sleep and Breathing Health · Combined Europe, Asia and other markets 496,616 457,363 +8.6%
Sleep and Breathing Health · Devices 2,665,173 2,444,011 +9.0%
Sleep and Breathing Health · Masks and other 1,839,717 1,657,161 +11.0%
Sleep and Breathing Health · U.S., Canada and Latin America 2,997,514 2,722,556 +10.1%
Sleep and Breathing Health · U.S., Canada and Latin America 1,654,413 1,522,758 +8.6%
Sleep and Breathing Health · U.S., Canada and Latin America 1,343,101 1,199,798 +11.9%
Show Geography breakouts
Rest of the World 1,860,746 1,705,244 +9.1%
US 3,285,581 2,980,053 +10.3%
Cost Of Goods And Service Excluding Depreciation Depletion And Amortization 2,059,241 1,997,031 +3.1%
Show Product Lines breakouts
Residential Care Software 195,043 190,186 +2.6%
Sleep and Breathing Health 1,864,198 1,806,845 +3.2%
Amortization Of Intangible Assets 32,116 32,963 -2.6%
Show Product Lines breakouts
Residential Care Software 25,470 27,448 -7.2%
Sleep and Breathing Health 6,646 5,515 +20.5%
Show Finite Lived Intangible Assets By Major Class breakouts
Identified Intangible Assets 77.4 79.5 -2.6%
Patents 8.2 7.6 +7.9%
Cost of Revenue 2,091,357 2,029,994 +3.0%
Show Business Segments breakouts
Residential Care Software · Operating Segments 195,043 190,186 +2.6%
Sleep and Breathing Health · Operating Segments 1,852,574 1,782,023 +4.0%
Show Consolidation Items breakouts
Operating Segments 2,047,617 1,972,209 +3.8%
Gross Profit 3,054,970 2,655,303 +15.1%
Selling, General & Administrative 991,019 917,136 +8.1%
Show Business Segments breakouts
Residential Care Software · Operating Segments 143,435 143,999 -0.4%
Sleep and Breathing Health · Operating Segments 491,591 451,334 +8.9%
Show Consolidation Items breakouts
Operating Segments 635,026 595,333 +6.7%
Research & Development 331,284 307,525 +7.7%
Show Business Segments breakouts
Residential Care Software · Operating Segments 97,959 95,490 +2.6%
Sleep and Breathing Health · Operating Segments 196,340 186,461 +5.3%
Show Consolidation Items breakouts
Operating Segments 294,299 281,951 +4.4%
Amortization Of Acquired Intangible Assets1 45,273 46,521 -2.7%
Show Consolidation Items breakouts
Material Reconciling Items 77,389 79,484 -2.6%
Business Combination Acquisition Related Costs 2,031
Show Consolidation Items breakouts
Material Reconciling Items 2,031
Operating Expenses 1,369,607 1,335,410 +2.6%
Operating Income 1,685,363 1,319,893 +27.7%
Show Business Segments breakouts
Residential Care Software · Operating Segments 205,000 154,450 +32.7%
Sleep and Breathing Health · Operating Segments 1,964,385 1,681,354 +16.8%
Show Consolidation Items breakouts
Operating Segments 2,169,385 1,835,804 +18.2%
Interest Income Expense Nonoperating Net 4,114 -45,708 +109.0%
Show Consolidation Items breakouts
Material Reconciling Items -4,114 45,708 -109.0%
Income Loss From Equity Method Investments 3,644 -1,848 +297.2%
Show Financial Instrument breakouts
Equity Method Investments 3,644 -1,848 +297.2%
Show Consolidation Items breakouts
Material Reconciling Items -3,644 1,848 -297.2%
Equity Securities Fv Ni Gain Loss -10,299 -4,045 -154.6%
Other Non-Operating Income (Expense) -5,256 -3,494 -50.4%
Show Consolidation Items breakouts
Material Reconciling Items 5,256 3,494 +50.4%
Non-Operating Income (Expense) -7,797 -55,095 +85.8%
Income Before Taxes 1,677,566 1,264,798 +32.6%
Show Consolidation Items breakouts
Material Reconciling Items 1,677,566 1,264,798 +32.6%
Income Tax Expense (Benefit) 276,843 243,847 +13.5%
Net Income 1,400,723 1,020,951 +37.2%
Show Equity Components breakouts
Retained Earnings 1,400,723 1,020,951 +37.2%
EPS (Basic) 9.55 6.94 +37.6%
EPS (Diluted) 9.51 6.92 +37.4%
Common Stock Dividends Per Share Declared 2.12 1.92 +10.4%
Wtd Avg Shares (Basic) 146,716 147,021 -0.2%
Wtd Avg Shares (Diluted) 147,340 147,550 -0.1%
Comprehensive Income 1,577,553 1,041,950 +51.4%

Balance Sheet

Balance Sheet
Metric FY 2025 FY 2024 YoY
Current Assets
Cash & Cash Equivalents 1,209,450 238,361 +407.4%
Show Cash And Cash Equivalents breakouts
High Yield Cash and Cash Equivalent 302.7
Accounts Receivable 939,492 837,275 +12.2%
Show Balance Sheet Location breakouts
Accounts receivable, net 939,492 837,275 +12.2%
Inventory 927,711 822,250 +12.8%
Prepaid Expenses & Other Current Assets 428,952 459,833 -6.7%
Total Current Assets 3,505,605 2,357,719 +48.7%
Non-Current Assets
Property, Plant & Equipment 550,790 548,025 +0.5%
Operating Lease Right-of-Use Assets 167,497 151,121 +10.8%
Goodwill 3,046,680 2,842,055 +7.2%
Show Business Segments breakouts
Residential Care Software 2,163,102 2,084,526 +3.8%
Sleep and Breathing Health 883,578 757,529 +16.6%
Intangible Assets 464,861 485,904 -4.3%
Show Finite Lived Intangible Assets By Major Class breakouts
Customer Relationships 286,491 281,984 +1.6%
Developed/core product technology 81,210 103,709 -21.7%
Other Intangible Assets 97,160 100,211 -3.0%
Deferred Income Taxes And Other Assets Noncurrent 253,119 203,569 +24.3%
Other Non-Current Assets 185,839 284,001 -34.6%
Assets Noncurrent 4,668,786 4,514,675 +3.4%
Total Assets 8,174,391 6,872,394 +18.9%
Current Liabilities
Accounts Payable 278,157 237,728 +17.0%
Accrued Liabilities 402,253 377,678 +6.5%
Operating Lease Liability Current 30,506 25,278 +20.7%
Deferred Revenue (Current) 166,030 152,554 +8.8%
Show Balance Sheet Location breakouts
Deferred revenue (current liabilities) 166,030 152,554 +8.8%
Accrued Income Taxes Current 132,274 107,517 +23.0%
Short Term Borrowings 9,900 9,900 0.0%
Total Current Liabilities 1,019,120 910,655 +11.9%
Non-Current Liabilities
Contract With Customer Liability Noncurrent 156,803 137,343 +14.2%
Show Balance Sheet Location breakouts
Deferred revenue (non-current liabilities) 156,803 137,343 +14.2%
Deferred Income Taxes And Other Tax Liabilities Noncurrent 77,682 79,339 -2.1%
Operating Lease Liabilities 153,015 141,444 +8.2%
Other Non-Current Liabilities 141,520 42,257 +234.9%
Long-Term Debt 658,392 697,313 -5.6%
Liabilities Noncurrent 1,187,412 1,097,696 +8.2%
Total Liabilities 2,206,532 2,008,351 +9.9%
Stockholders' Equity
Common Stock Value Outstanding 761 588 +29.4%
Additional Paid In Capital Common Stock 2,033,599 1,896,604 +7.2%
Retained Earnings 6,081,490 4,991,647 +21.8%
Treasury Stock Common Value -2,073,292 -1,773,267 -16.9%
Accumulated Other Comprehensive Income -74,699 -251,529 +70.3%
Total Stockholders' Equity 5,967,859 4,864,043 +22.7%
Show Equity Components breakouts
Accumulated Other Comprehensive Income -74,699 -251,529 +70.3%
Additional Paid In Capital 2,033,599 1,896,604 +7.2%
Common Stock 761 588 +29.4%
Retained Earnings 6,081,490 4,991,647 +21.8%
Treasury Stock Common -2,073,292 -1,773,267 -16.9%
Total Liabilities & Equity 8,174,391 6,872,394 +18.9%

Cash Flow Statement

Cash Flow Statement
Metric FY 2025 FY 2024 YoY
Operating Activities
Depreciation & Amortization 198,473 176,870 +12.2%
Show Business Segments breakouts
Residential Care Software · Operating Segments 9,467 10,241 -7.6%
Sleep and Breathing Health · Operating Segments 110,543 86,070 +28.4%
Show Consolidation Items breakouts
Corporate Non Segment 78,463 80,559 -2.6%
Operating Lease Right Of Use Asset Amortization Expense 37,338 39,339 -5.1%
Stock-Based Compensation 91,661 80,184 +14.3%
Income Loss From Equity Method Investments Net Of Dividends Or Distributions -3,644 1,848 -297.2%
Debt And Equity Securities Unrealized Gain Loss 10,299 4,045 +154.6%
Show Consolidation Items breakouts
Material Reconciling Items -10,299 -4,045 -154.6%
Change in Accounts Receivable -76,684 -134,278 +42.9%
Change in Inventory -80,165 172,203 -146.6%
Change in Prepaid & Other Assets 82,629 -115,213 +171.7%
Increase Decrease In Accounts Payable And Accrued Liabilities 90,958 122,072 -25.5%
Net Cash from Operations 1,751,588 1,401,260 +25.0%
Deferred Income Taxes -60,990 -49,878 -22.3%
Investing Activities
Capital Expenditures -89,865 -99,460 +9.6%
Payments To Acquire Intangible Assets -10,777 -15,396 +30.0%
Payments To Acquire Businesses Net Of Cash Acquired -139,248 -133,464 -4.3%
Payments To Acquire Investments -6,416 -12,765 +49.7%
Proceeds From Sale Maturity And Collections Of Investments 4,628 1,000 +362.8%
Payments For Proceeds From Derivative Instrument Investing Activities 41,633 -9,699 +529.3%
Net Cash from Investing -200,045 -269,784 +25.8%
Financing Activities
Proceeds From Issuance Of Common Stock 74,439 53,094 +40.2%
Tax Withholding for Share Compensation -18,077 -8,757 -106.4%
Share Repurchases -300,025 -150,011 -100.0%
Payments Of Merger Related Costs Financing Activities -855 -1,293 +33.9%
Acquisition Of Consolidated Subsidiary Financing Activities -10,855
Repayments Of Long Term Debt -40,000 -835,000 +95.2%
Payments Of Dividends -310,880 -282,320 -10.1%
Net Cash from Financing -606,253 -1,119,287 +45.8%
Supplemental
Income Taxes Paid 214,013 278,400 -23.1%
Interest Paid 28,415 45,708 -37.8%
Noncash Part Of Acquisition Fair Value Of Assets Acquired 43,534 46,033 -5.4%
Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 -6,279 -7,696 +18.4%
Goodwill Acquired During Period Increase Decrease 101,323 92,191 +9.9%
Deferred Payment Obligations For Acquisitions 670 -143 +568.5%
Business Acquisition Contingent Consideration Recognized Liability 855 4,372 -80.4%
Payments To Acquire Businesses Gross 140,103 134,757 +4.0%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 25,799 -1,719 +1600.8%
Net Change in Cash 971,089 10,470 +9175.0%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1,209,450 238,361 +407.4%

Values in thousands USD. Source: SEC EDGAR 10-K filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key